<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
TheFly.com
< Back to all Breaking News
MRK
8/3/2022 06:08am
4 Street Research Stories
6 Calendar Events
Merck says Phase 3 KEYNOTE-921 trial did not meet dual primary endpoints

Copyright ©1998-2024 Thefly.com LLC
ABOUT THE FLY
ABOUT THE FLY Services About Us Help/FAQ Careers Disclaimer And Terms Of Use Privacy Policy Cancellation Policy Limit the use of my sensitive personal information
SUBSCRIPTIONS
SUBSCRIPTIONS Basic Plan Full Plan
NEWS
NEWS Breaking News On The Fly
CALENDARS
CALENDARS Events Syndicate
STAY CONNECTED
STAY CONNECTED Contact Us
dynamic_feed Breaking News